FR2821080B1 - SPECIFIC ANTIBODIES TO HUMAN ADRENOMEDULLINE, PHARMACEUTICAL COMPOSITION CONTAINING SAME, ITS THERAPEUTIC APPLICATIONS - Google Patents

SPECIFIC ANTIBODIES TO HUMAN ADRENOMEDULLINE, PHARMACEUTICAL COMPOSITION CONTAINING SAME, ITS THERAPEUTIC APPLICATIONS

Info

Publication number
FR2821080B1
FR2821080B1 FR0102291A FR0102291A FR2821080B1 FR 2821080 B1 FR2821080 B1 FR 2821080B1 FR 0102291 A FR0102291 A FR 0102291A FR 0102291 A FR0102291 A FR 0102291A FR 2821080 B1 FR2821080 B1 FR 2821080B1
Authority
FR
France
Prior art keywords
adrenomedulline
human
pharmaceutical composition
composition containing
specific antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0102291A
Other languages
French (fr)
Other versions
FR2821080A1 (en
Inventor
L Houcine Ouafik
Pierre Marie Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Priority to FR0102291A priority Critical patent/FR2821080B1/en
Priority to AU2002238673A priority patent/AU2002238673A1/en
Priority to PCT/FR2002/000638 priority patent/WO2002066492A2/en
Publication of FR2821080A1 publication Critical patent/FR2821080A1/en
Application granted granted Critical
Publication of FR2821080B1 publication Critical patent/FR2821080B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
FR0102291A 2001-02-20 2001-02-20 SPECIFIC ANTIBODIES TO HUMAN ADRENOMEDULLINE, PHARMACEUTICAL COMPOSITION CONTAINING SAME, ITS THERAPEUTIC APPLICATIONS Expired - Fee Related FR2821080B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0102291A FR2821080B1 (en) 2001-02-20 2001-02-20 SPECIFIC ANTIBODIES TO HUMAN ADRENOMEDULLINE, PHARMACEUTICAL COMPOSITION CONTAINING SAME, ITS THERAPEUTIC APPLICATIONS
AU2002238673A AU2002238673A1 (en) 2001-02-20 2002-02-20 Human adrenomedullin-specific antibody, pharmaceutical composition containing same, therapeutic uses thereof
PCT/FR2002/000638 WO2002066492A2 (en) 2001-02-20 2002-02-20 Human adrenomedullin-specific antibody, pharmaceutical composition containing same, therapeutic uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0102291A FR2821080B1 (en) 2001-02-20 2001-02-20 SPECIFIC ANTIBODIES TO HUMAN ADRENOMEDULLINE, PHARMACEUTICAL COMPOSITION CONTAINING SAME, ITS THERAPEUTIC APPLICATIONS

Publications (2)

Publication Number Publication Date
FR2821080A1 FR2821080A1 (en) 2002-08-23
FR2821080B1 true FR2821080B1 (en) 2003-12-19

Family

ID=8860234

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0102291A Expired - Fee Related FR2821080B1 (en) 2001-02-20 2001-02-20 SPECIFIC ANTIBODIES TO HUMAN ADRENOMEDULLINE, PHARMACEUTICAL COMPOSITION CONTAINING SAME, ITS THERAPEUTIC APPLICATIONS

Country Status (3)

Country Link
AU (1) AU2002238673A1 (en)
FR (1) FR2821080B1 (en)
WO (1) WO2002066492A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040121375A1 (en) * 2002-09-30 2004-06-24 Bayer Pharmaceuticals Corporation Methods for prediction and prognosis of cancer, and monitoring cancer therapy
JO3382B1 (en) 2008-12-23 2019-03-13 Amgen Inc Human cgrp receptor binding antibodies
FR2964103B1 (en) * 2010-08-30 2018-11-23 Universite D'aix-Marseille ANTIBODIES BINDING TO ADRENOMEDULLINE AND RECEPTORS OF ADRENOMEDULLINE AND THEIR USES AS A MEDICINAL PRODUCT
EP2589963A1 (en) * 2011-11-04 2013-05-08 Université de Provence (Aix-Marseille 1) Diagnostic and treatment of an androgen-independent prostate cancer
AR101875A1 (en) 2014-09-15 2017-01-18 Amgen Inc ANTIGENS, BI-SPECIFIC UNION PROTEIN OF THE ANTI-CGRP RECEIVER / PAC1 RECEIVER AND USES OF THE SAME
JOP20200116A1 (en) 2015-04-24 2017-06-16 Amgen Inc Methods for treating or preventing migraine headache
AR114722A1 (en) 2018-04-02 2020-10-07 Amgen Inc COMPOSITIONS OF ERENUMAB AND USES OF THEM

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2774769B2 (en) * 1993-04-26 1998-07-09 賢治 寒川 Adrenomedullin
EP0845036B1 (en) * 1995-08-18 1999-06-02 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology

Also Published As

Publication number Publication date
WO2002066492A3 (en) 2003-02-27
FR2821080A1 (en) 2002-08-23
AU2002238673A1 (en) 2002-09-04
WO2002066492A2 (en) 2002-08-29

Similar Documents

Publication Publication Date Title
FR16C1012I2 (en) THERAPEUTIC USE OF ANTI-CS1 ANTIBODIES
EA200300081A1 (en) HYDROGEL-CONTROLLED MEDICINE FORM
ATE361084T1 (en) TOPICAL PHARMACEUTICAL COMPOSITIONS CONTAINING PROANTHOCYANIDINS, GLYCYRRHETINIC ACID AND TELMESTEINS FOR THE TREATMENT OF DERMATITIS
BG66080B1 (en) Substituted thioacetamides
SE0001899D0 (en) New compounds
RU2325389C2 (en) Composition and derivatives of substituted azaindoloxoacetapiperazine characterized by antiviral activity
FR2825277B1 (en) COSMETIC AND / OR DERMATOLOGICAL AND / OR PHARMACEUTICAL COMPOSITION CONTAINING AT LEAST ONE ENZIME 3, B-HSD IHNIBITOR COMPOUND
DE50206657D1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MULTIPLE SCLEROSIS
EA200100524A1 (en) AMIDES OF ANTRANILIC ACID AND THEIR APPLICATION AS MEDICINES
CY1108672T1 (en) PHARMACEUTICAL PACKAGING PRODUCT FOR MICROBIOLOGICAL TREATMENT
ATE353327T1 (en) THIOPHENE COMPOUNDS AS MEDICINAL PRODUCTS
FR2834890B1 (en) ORODISPERSIBLE PHARMACEUTICAL COMPOSITION OF AGOMELATIN
ATE543491T1 (en) COMBINATION PREPARATION CONTAINING IBUPROFEN AND PARACETAMOL
DE60219051D1 (en) PYRIMIDONE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ES2168457T3 (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A DISMUTE SUPEROXIDE.
ATE308328T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING CLINDAMYCIN AND CLOTRIMAZOLE, FOR THE TREATMENT OF VAGINAL INFECTIONS
SE9901077D0 (en) Novel use
FR2773486B1 (en) LIPS CARE COMPOSITION CONTAINING ACEXAMIC ACID, USES THEREOF
ES2144054T3 (en) TRI COMPLEXES (PLATINUM).
FR2821080B1 (en) SPECIFIC ANTIBODIES TO HUMAN ADRENOMEDULLINE, PHARMACEUTICAL COMPOSITION CONTAINING SAME, ITS THERAPEUTIC APPLICATIONS
FR2857263B1 (en) NOVEL SOLID PHARMACEUTICAL COMPOSITION COMPRISING AMISULPRIDE
FR2812811B1 (en) PHARMACEUTICAL COMPOSITION CONTAINING CITALOPRAM
FR2834896B1 (en) ORODISPERSIBLE PHARMACEUTICAL COMPOSITION OF IVABRADINE
FR2869611B1 (en) HEXENOIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND THERAPEUTIC APPLICATIONS
MXPA04001655A (en) Ascorbic acid derivatives, methods of synthesis and pharmaceutical use thereof.

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse

Effective date: 20151030